What is the appropriate albumin infusion protocol, including indications, dosing, and monitoring, for adult patients with clinically significant hypoalbuminemia or requiring plasma volume expansion?

Albumin Infusion Protocol

Albumin should NOT be used routinely for volume resuscitation or to correct hypoalbuminemia in most hospitalized patients, with the notable exceptions of cirrhosis-related complications (large-volume paracentesis and spontaneous bacterial peritonitis) where it demonstrates clear mortality and morbidity benefits. 1

Evidence-Based Indications for Albumin Use

Strong Indications (Use Albumin)

Cirrhosis with Spontaneous Bacterial Peritonitis:

• Dosing: 1.5 g/kg on day 1 and 1.0 g/kg on day 3 (hyperoncotic 20-25% albumin) 1
• Evidence: Reduces kidney impairment (OR 0.21) and mortality (OR 0.34) when combined with antibiotics 1
• Administration: Given in addition to antibiotic therapy 1

Cirrhosis with Large-Volume Paracentesis (>5L):

• Dosing: 6-8 g of albumin per liter of ascitic fluid removed 1
• Alternative dosing: Standard dose of 20-40 g 1
• Evidence: Prevents paracentesis-induced circulatory dysfunction (RR 1.98 for dysfunction with non-albumin expanders vs albumin) 1
• Formulation: Use hyperoncotic albumin (20-25%) 1, 2

Conditional/Limited Indications (Consider Albumin as Second-Line)

Hypovolemic Shock:

• When to consider: After initial crystalloid resuscitation in patients with severe hypoalbuminemia (serum albumin ≤2.5 g/dL) 3, 4
• Dosing: Total dose should not exceed 2 g/kg body weight in absence of active bleeding 3
• Formulation: 25% albumin (Plasbumin-25) with appropriate crystalloids 3
• Administration rate: Do not exceed 2 mL/min in hypoproteinemic patients to avoid circulatory overload 3
• Mechanism: Hyperoncotic 25% albumin expands plasma volume 3-4 times the infused volume by recruiting interstitial fluid 3, 5

Burns (Beyond 24 Hours):

• Target: Maintain plasma albumin ≥2.5 g/dL (plasma oncotic pressure 20 mmHg) 3
• Formulation: Use 25% albumin 3
• Duration: Based on protein loss from burned areas and urine 3

Severe Hypoproteinemia with Refractory Edema:

• Dosing: Adults 50-75 g daily, children 25 g daily 3
• Administration rate: Maximum 2 mL/min to prevent pulmonary edema 3
• Caveat: Only if underlying pathology cannot be corrected; this is symptomatic treatment only 3

Strong Recommendations AGAINST Albumin Use

Critical Care (General):

• Do NOT use albumin for first-line volume replacement in critically ill adults (excluding thermal injuries and ARDS) 1
• Do NOT use albumin to increase serum albumin levels 1
• Evidence: No mortality benefit (risk difference 0.00), no reduction in kidney failure, ICU/hospital length of stay, or blood loss 1

Cardiovascular Surgery:

• Do NOT use albumin routinely for cardiopulmonary bypass priming or volume expansion 1
• Evidence: Largest trial (1,386 patients) showed INCREASED rates of bleeding, resternotomy, and infection with 4% albumin vs Ringer's lactate 1
• Exception: Role in high-risk cardiac surgery remains unstudied 1

Heart Failure with Hypoalbuminemia:

• Do NOT use albumin in heart failure patients with serum albumin ≤2.9 g/dL 6
• Evidence: Associated with increased in-hospital mortality and prolonged ICU/hospital stays 6

Sepsis/COVID-19:

• Limited evidence: Early albumin administration did not reduce 28-day mortality in severe COVID-19 patients 7
• Ongoing trial: INCEPT-Albumin trial (up to 10,000 patients) is evaluating albumin in ICU shock patients 8

Administration Guidelines

Preparation and Infusion:

• Swab stopper with antiseptic before entering vial 3
• Use only 16-gauge needles for 20 mL vials and larger 3
• May be administered undiluted or diluted in 0.9% NaCl or 5% dextrose 3
• For sodium restriction: use undiluted or dilute only in 5% dextrose 3

Monitoring During Infusion:

• Monitor hemodynamic response continuously 3
• Watch for signs of circulatory overload, especially in hypoproteinemic patients 3
• Maximum plasma volume expansion occurs 20 minutes after completing hyperoncotic albumin infusion 5

Critical Pitfalls to Avoid

Do not use albumin for:

• Routine correction of low serum albumin levels (hypoalbuminemia alone is not an indication) 1, 2
• Nutritional support 3, 2
• First-line volume resuscitation in most clinical scenarios 1
• Modest volume paracentesis (<5L) - weak evidence only 2

Recognize contraindications:

• Dehydrated patients require additional crystalloids or 5% albumin instead of 25% 3
• Rapid infusion in hypoproteinemic patients risks pulmonary edema 3

Cost considerations:

• Albumin costs approximately $130 per 25g (US warehouse acquisition cost) 1
• Use only when evidence supports improved morbidity/mortality outcomes 1

Evidence Quality Summary

The 2024 International Collaboration for Transfusion Medicine Guidelines reviewed 14 recommendations: only 2 had moderate certainty evidence, while 12 recommendations advised against albumin use in common clinical situations 1. The strongest evidence supports albumin use specifically in cirrhosis complications, with most other indications lacking definitive outcome benefits 1.